const data = {
  id: 'advisors',
  smallTitle: 'Scientific Advisors',
  title: 'Independent researchers, clinicians, and thought leaders broaden our perspective, expand our understanding, and augment internal research efforts.',
  items: [
    {
      image: {
        href: '/images/advisors/shahid_nimjee.png'
      },
      name: 'Shahid Nimjee',
      job: 'Professor of Neurosurgery and Neuroscience',
      description: 'Shahid Nimjee, MD, PhD is an Associate Professor of Neurosurgery and Neuroscience and the Surgical Director of the Comprehensive Stroke Center at The Ohio State University Wexner Medical Center (OSUWMC), where he treats stroke patients.',
      text: 'Shahid Nimjee, MD, PhD is an Associate Professor of Neurosurgery and Neuroscience and the Surgical Director of the Comprehensive Stroke Center at The Ohio State University Wexner Medical Center (OSUWMC), where he treats stroke patients. Dr. Nimjee also leads a foundational and translational research laboratory at OSUWMC focused on developing novel therapies to treat patients with ischemic stroke. He is the co-founder and Chief Medical Officer of Basking Biosciences, a biotechnology company developing the first thrombolytic therapy with a ready reversal agent to treat patients who present with acute ischemic stroke.'
    },
    {
      image: {
        href: '/images/advisors/ryan_fields.png'
      },
      name: 'Ryan Fields',
      job: 'Chief of Surgical Oncology',
      description: 'Ryan Fields, M.D., F.A.C.S. is the Chief of Surgical Oncology at Barnes-Jewish Hospital and the Alvin J. Siteman Comprehensive Cancer Center at Washington University School of Medicine, where he is the Kim and Tim Eberlein Distinguished Professor of Surgical Oncology. ',
      text: 'Ryan Fields, M.D., F.A.C.S. is the Chief of Surgical Oncology at Barnes-Jewish Hospital and the Alvin J. Siteman Comprehensive Cancer Center at Washington University School of Medicine, where he is the Kim and Tim Eberlein Distinguished Professor of Surgical Oncology. Dr. Fields’ translational research laboratory focuses on the biology and genetics of cancer metastasis, small animal and ex vivo models of cancer, and oncologic imaging. Dr. Fields also serves as Director of the Washington University Solid Tumor Tissue Bank and Registry. He is the Co-Leader of the Solid Tumor Therapeutics Program and the Melanoma and Cutaneous Oncology Program at Barnes-Jewish Hospital and the Alvin J. Siteman Comprehensive Cancer Center.'
    },
    {
      image: {
        href: '/images/advisors/rahul_khurana.png'
      },
      name: 'Rahul N. Khurana',
      job: 'Vitreoretinal surgeon',
      description: 'Rahul N. Khurana, MD, is a vitreoretinal surgeon and Partner at Northern California Retina Vitreous Associates, one of the largest retina practices in California. Dr. Khurana is a national thought leader in retinal disease and clinical trials.',
      text: "Rahul N. Khurana, MD, is a vitreoretinal surgeon and Partner at Northern California Retina Vitreous Associates, one of the largest retina practices in California. Dr. Khurana is a national thought leader in retinal disease and clinical trials. He is also a Clinical Associate Professor of Ophthalmology at the University of California, San Francisco. He currently serves as the Secretary of Online Education for the American Academy of Ophthalmology (AAO), which includes Eyewiki, the Ophthalmic News and Education (ONE) Network, and Clinical Webinars; and the Past President of the California Academy of Eye Physicians and Surgeons. He was the Editor-in-Chief of the AAO's ONE Network."
    }
  ]
}

export default data;